Cytocast

22/10/2025

📣 We’re thrilled to announce the grand release of THREE powerful new products at Cytocast: Screener, Optimizer, and Nominator! 🎉

After extensive work improving our training sets, incorporating our pilot partner’s feedback, enhancing features, and delivering fully interactive reports, these tools are designed to transform your drug discovery and cell simulation workflows.

🔍 Cytocast Screener: Pre-synthesis triage (dry → wet).
Ranks thousands, flags side-effect risks to eliminate weak candidates early to save time and cost.

⚙ Cytocast Optimizer: Early–late preclinical refinement.
Gives actionable insights on top candidates and mechanisms of potential side effects to confidently down-select.

✨ Cytocast Nominator: Lead and backup selection.
Delivers in-depth reports quantifying adverse-event risk to de-risk trials.

These advancements reflect our commitment to innovation and user-driven development. If you’re curious to see how Cytocast can empower your research and development, contact us today!

Let’s push the boundaries of biotechnology together.

31/03/2025

🔬 A decade ago, editing genes was a slow, labor-intensive process. Today, researchers are exploring AI-powered simulations with the potential to predict genetic modifications more effectively.

💊At Cytocast, we're excited about the future possibilities of AI in biology, imagining a world where we can anticipate how gene edits might influence entire biological systems, dramatically reducing trial-and-error and opening doors to faster scientific breakthroughs.

🤔But here's a thought: Could we uncover genetic possibilities we don't yet fully understand as AI advances?

❓Would you feel comfortable trusting AI-guided gene editing in humans, or should we always ensure human oversight?

Let's discuss — I'm curious to hear your perspectives! 👇

28/03/2025

TechBio vs. Biotech: what’s the difference?

🔬 Biotech focuses on molecular biology, genetic engineering, and lab research to develop new drugs and therapies.

🤖 TechBio leverages AI, big data, and computational biology to simulate biological processes, accelerating drug discovery before wet-lab experiments begin.

🔑 Key distinction? Biotech engineers life in the lab, while TechBio models life digitally to optimize real-world applications.

At Cytocast, we're firmly in the TechBio space—using AI and computational approaches to envision the future of biology.

Are we heading toward a TechBio-driven future? Let’s discuss! 👇

https://cytocast.com/

28/03/2025

👉The latest blog post from Cytocast explores how virtual drug testing revolutionizes pharmaceutical development...

👉 Read more here: https://cytocast.com/blog/virtual-drug-testing-cell-simulations/

20/03/2025

🎉Excited to announce that our team will be presenting at the upcoming Hungarian Molecular Life Science Conference 2025 in Eger from March 28-30! We'll be sharing our latest research through two oral presentations and two poster sessions:

🗣🔈Oral Presentations (Saturday noon):

Predicting drug side effects using Digital Twins – Fichó
Linking drug side effects with their binding to specific off-target proteins via a cell simulation-based and interpretable machine learning method – Ecker

📝Poster Presentations (Friday evening):

Predicting novel complexes using a data-driven cell simulator – Weber
Unravelling cellular regulation on the structural level: a novel concept to event-driven agent-based modeling of interaction networks – Kovács

🤝Looking forward to engaging with fellow researchers and exploring the latest advancements in molecular life sciences!

🌐https://2025.hunlifesci.hu/scientific-programme/

14/03/2025

📝🎉We are proud to announce that our team members — Fichó, Szalma, and Csikász-Nagy — have contributed to a groundbreaking study published in Nature Neuroscience:

👉Microglia dysfunction, neurovascular inflammation and focal neuropathologies are linked to IL-1- and IL-6-related systemic inflammation in COVID-19

🧐The research uncovers an epigenetic mechanism that regulates the timing of human neuronal maturation, offering new insights into brain development. This discovery holds significant potential for advancing our understanding of neurological diseases and developing novel therapeutic strategies.

💪We are proud to be part of this innovative work that exemplifies our commitment to pushing the boundaries of scientific knowledge.

🌐https://rpb.li/dVq

The authors show that brain inflammation in COVID-19 correlates with viral load, systemic inflammation and virus-sensing pattern recognition receptors. Microglial dysfunction occurs at sites of vascular inflammation with myelin injury and synapse loss.

11/03/2025

📌COVID-19 doesn’t just affect the lungs—it also has profound effects on the brain and nervous system. Cytocast’s latest article" explores how the virus contributes to microglial dysfunction, vascular inflammation, and long-term neurological damage. 🔬

Read the full article:

🧐https://rpb.li/OHou

07/03/2025

📌Technological advancements are reshaping healthcare, biology, and the pharmaceutical industry, yet the terms , , and are often used interchangeably. Know the differences!

🧐Read our latest article!

👉https://rpb.li/CTLQ

05/03/2025

/Scroll down for ENG/

⚖A Cytocastnál hisszük, hogy a társadalmi felelősségvállalás nem egy kipipálandó feladat, hanem olyan kötelesség, ami nekünk is örömet okoz. Ezért örömmel csatlakoztunk a kampányhoz, amely rászoruló nőknek nyújt segítséget alapvető higiéniai termékek adományozásával.

🌏Munkánk során egy jobb világért dolgozunk, most pedig az irodán kívül is szeretnénk hozzájárulni egy fontos ügyhöz, mert hiszünk abban, hogy az apró tettek is nagy változást hozhatnak.

❗Csatlakozzatok Ti is! Részletek: 👉 https://nemluxustaska.hu/

/ENG/

At Cytocast, we believe that social responsibility is not just a task to check off a list but a duty that brings us joy as well. That’s why we are happy to join the campaign, which supports women in need by providing essential hygiene products.

In our work, we strive for a better world, and now we want to contribute to an important cause outside the office as well—because we believe that even small actions can lead to big changes.

Join us in making a difference! Learn more: 👉 https://nemluxustaska.hu/

04/03/2025

♟Participating in the Venture Capital Investment Competition (VCIC) was an invaluable experience.

👉This unique event allows startups to pitch to students acting as venture capitalists, providing a realistic simulation of the fundraising process. The intensive due diligence and feedback from students and seasoned VCs offered us deep insights into our business model and pitch effectiveness.

📉We highly recommend to fellow entrepreneurs looking to refine their fundraising strategies and gain exposure to a diverse group of aspiring and professional investors.